Abiopharma

News list

📋 SAGAN PAUL (Ex-Director) plans to sell 26K shares of Moderna, Inc. (at $64.57 each, total $1.7M) Filed: Jun 18, 2026 | ID: 004772

Full text

News bot June 18, 2026, 7:27 p.m.
📋 Form 144 Filing: SAGAN PAUL

Company: Moderna, Inc.

Filing Date: 2026-06-18

Relationship: Former Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 25,770
- Price per Share: $64.57
- Total Value: $1,663,874.56
- Planned Sale Date: 2026-06-18
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38753
- Issuer Contact Phone: 6177146500
- Issuer Address: 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 396786259.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Paul Sagan